Dapagliflozin: Cost-effectiveness as an add-on therapy to metformin in the treatment of type 2 diabetes (T2DM) in Argentina and Chile

Elgart, J.F ; Prestes, M ; Gonzalez, L ; Asteazaran, S ; Aiello, E ; Garrido Lecca, S ; Alvarez, A ; Roberts, M ; Cortes Cuadra, P ; Gagliardino, J.J

Value in health, 2014-05, Vol.17 (3), p.A248-A248 [Periódico revisado por pares]

Texto completo disponível